Got $3,000? Here Are My Top 3 Artificial Intelligence (AI) Stocks to Buy Right Now

The article argues Microsoft, Nvidia, and Nebius are attractive AI stocks, citing Microsoft’s 123% AI business growth and 40% cloud growth, Nvidia’s forward P/E of 23x falling to 16x on next year’s estimates, and Nebius revenue up 684% in Q1. It also highlights Nebius’s expansion target to $7B-$9B in annual recurring revenue by end-2026 versus $1.25B at end-2025. Overall tone is bullish on AI infrastructure and valuation mispricing, but the piece is largely opinion-driven rather than new company-specific news.

Analysis

The market is treating AI infrastructure as one trade, but the dispersion here is the story: the best risk-adjusted exposure is not the highest-growth name, it is the platform with the widest margin of error and the most diversified demand stack. That favors MSFT over the pure plays because its AI monetization is effectively being cross-subsidized by an entrenched enterprise distribution channel, which lowers the probability of a multiple reset if AI capex slows for a quarter or two.

NVDA still has the cleanest second-order benefit from the ongoing compute buildout, but the more interesting setup is that its dominance can coexist with multiple expansion in adjacent infrastructure names while the market remains underpenetrated in the “pick-and-shovel” layer. If hyperscaler spend keeps rising, the incremental winner is not necessarily the next model provider; it is the company that controls the bottleneck in deployment, networking, and accelerated throughput. That argues for watching the capital chain rather than just headline revenue growth.

NBIS is the high-beta expression of that bottleneck trade, but it is also the most fragile if financing or hardware access tightens. Its upside is path-dependent on execution staying ahead of capacity additions; any delay in bringing supply online would compress the valuation quickly because the stock already discounts a large part of the growth narrative. In other words, the base case is powerful, but the drawdown profile is ugly if the market decides the growth curve is lumpy rather than linear.

The contrarian miss is that the consensus may be underestimating how much of the AI spend cycle is already priced into the mega-cap winners, while underestimating how quickly smaller infrastructure names can rerate on supply scarcity. The better trade is probably not a blanket long AI basket, but a barbell: own the cash-rich compounding platform and selectively express upside through a smaller-cap AI infrastructure name with strict sizing. Near-term catalysts are earnings guide-ups and cloud capex commentary; the main risk is that hyperscaler spend decelerates before the next supply wave lands, which would hit the high-multiple names first.

Key Decisions for Investors

• Stay long MSFT as the core AI compounder; use it as the lower-volatility anchor in the basket. Best held over 6-12 months with limited downside versus the more speculative AI infrastructure names.
• Maintain long NVDA, but avoid chasing strength intraday; add on any 5-8% pullback tied to capex digestion fears. Risk/reward remains favorable for a 6-9 month horizon if hyperscaler spending stays elevated.
• Small-capellite long NBIS only as a tactical high-beta position, sized at 25-33% of a standard single-name risk budget. Best entry is on post-rally consolidation; upside is outsized, but treat it as a trade, not a core book position.
• Pair trade: long MSFT / short a basket of weaker AI infrastructure proxies that lack balance-sheet strength or locked-in demand. The goal is to isolate AI exposure while fading names most vulnerable to financing and execution risk.
• If using options, prefer NVDA call spreads 3-6 months out rather than outright calls; this captures continued upside from capex momentum while reducing premium bleed if the market pauses on valuation.